SMS PHARMACEUTICALS
Back to Balance Sheet
|
SMS PHARMACEUTICALS Last 5 Year Net Current Assets History
[Consolidated]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
---|---|---|---|---|---|
Net Current Assets (Including Current Investments) | ₹156 Cr | ₹181 Cr | ₹114 Cr | ₹74 Cr | ₹65 Cr |
What is the latest Net Current Assets ratio of SMS PHARMACEUTICALS ?
Year | Net Current Assets |
---|---|
Mar2023 | ₹156 Cr |
Mar2022 | ₹181 Cr |
Mar2021 | ₹114 Cr |
Mar2020 | ₹74 Cr |
Mar2019 | ₹65 Cr |
How is Net Current Assets of SMS PHARMACEUTICALS Trending?
Years | Net Current Assets | % Change | |
---|---|---|---|
Mar2023 | ₹156 Cr | -13.75 | |
Mar2022 | ₹181 Cr | 58.53 | |
Mar2021 | ₹114 Cr | 54.81 | |
Mar2020 | ₹74 Cr | 13.12 | |
Mar2019 | ₹65 Cr | - |
Compare Net Current Assets of peers of SMS PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
SMS PHARMACEUTICALS | ₹1,701.6 Cr | -3.3% | 7.8% | 154.9% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹361,916.0 Cr | 0.3% | -7.5% | 53.9% | Stock Analytics | |
CIPLA | ₹115,034.0 Cr | 1.1% | -4.8% | 56.4% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹105,929.0 Cr | 1.6% | 1.6% | 27.6% | Stock Analytics | |
DIVIS LABORATORIES | ₹104,873.0 Cr | -1.9% | 10.7% | 21.4% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹100,322.0 Cr | 5.2% | -0.2% | 90.1% | Stock Analytics |
SMS PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
SMS PHARMACEUTICALS | -3.3% |
7.8% |
154.9% |
SENSEX | -0.6% |
0.3% |
21.8% |
You may also like the below Video Courses